![Edwin Tucker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edwin Tucker
Corporate Officer/Principal chez
The Royal College of Physicians
Fortune : 1 277 $ au 31/05/2026
Profil
Edwin J.
Tucker is currently a Member at The Royal College of Physicians.
Former roles include Chief Medical Officer at Jasper Therapeutics, Inc. (2023–2025), Chief Medical Officer at Mirum Pharmaceuticals, Inc. (2019–2021), Chief Operating Officer at Acerta Pharma LLC (2018–2019), Chief Medical Officer at Goldfinch Bio, Inc., Vice President-Global Safety at Genentech, Inc. (2013–2015), and Vice President-Global Safety at Johnson & Johnson (2010–2013).
Education includes a doctorate from the University of Leeds and an MBA from the University of Connecticut.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 1 540 ( 0,01 % ) | 1 277 $ | 31/05/2026 |
Postes actifs de Edwin Tucker
| Sociétés | Poste | Début |
|---|---|---|
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Edwin Tucker
| Sociétés | Poste | Fin |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/08/2025 |
| MIRUM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2021 |
Acerta Pharma LLC
 Acerta Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in drug development | Compliance Officer | 01/01/2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/2015 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2013 |
Formation de Edwin Tucker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
98
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Acerta Pharma LLC
Acerta Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in drug development | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
